Endogenous Interleukin-33 Acts as an Alarmin in Liver Ischemia-Reperfusion and Is Associated With Injury After Human Liver Transplantation

Louise Barbier(Université de Tours), Ephrem Salamé(Université de Tours)
Frontiers in Immunology
September 21, 2021
10.3389/fimmu.2021.744927
Cited by 19

Related Papers

Interleukin-1 Family Cytokines: Keystones in Liver Inflammatory Diseases
|Frontiers in Immunology|2019|179
Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial
|The Lancet|2024|153
Early activation and recruitment of invariant natural killer T cells during liver ischemia-reperfusion: the major role of the alarmin interleukin-33
|Frontiers in Immunology|2023|4